RENEWABLES INFRA GRP LTD by Renewables Infrastructure Group, Ltd. Stock (OTC: RWFRF)

Latest news for RENEWABLES INFRA GRP LTD by Renewables Infrastructure Group, Ltd. (OTC:RWFRF) Stock

RENEWABLES INFRA GRP LTD by Renewables Infrastructure Group, Ltd.

WIIM

RPM International shares are trading higher after the company reported better-than-expected Q4 earnings.

JP Morgan analyst Thomas Palmer maintains Lamb Weston Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LW#NYSE">LW</a>) with a Overweight and lowers the price target from $108 to $63.

News

Price Target

Analyst Ratings

JP Morgan Maintains Overweight on Lamb Weston Hldgs, Lowers Price Target to $63

FCNCA

First Citizens shares are trading higher after the company reported better-than-expected earnings.

ICLR

ICON Plc shares are trading lower after the company reported worse-than-expected Q2 revenue.

<ul>
<li>A one-time dose of DURVEQTIX has reduced bleeds post-treatment compared to standard of care with a median annualized bleed rate (ABR) of zero bleeds (range 0 to 9.9) after up to four years of follow-up, providing sustained bleed protection and potentially avoiding years of treatment burden with prophylaxis for many patients.</li>
</ul>
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.pfizer.com%2F&amp;esheet=54099588&amp;newsitemid=20240725789026&amp;lan=en-US&amp;anchor=Pfizer+Inc.&amp;index=1&amp;md5=acf2f3bb0942d5a84c03e4474efe98a4">Pfizer Inc.</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) today announced that the European Commission (EC) has granted conditional marketing authorization for DURVEQTIX&#xAE; (fidanacogene elaparvovec), a gene therapy for the treatment of severe and moderately severe hemophilia B (congenital factor IX deficiency) in adult patients without a history of factor IX inhibitors and without detectable antibodies to variant AAV serotype Rh74. DURVEQTIX is designed to enable people living with hemophilia B to produce factor IX (FIX) themselves via a one-time dose, rather than multiple intravenous FIX infusions weekly or biweekly with the current standard of care.1,2,3

Legal

Global

European Commission Approves Pfizer's DURVEQTIX, A One-Time Gene Therapy For Adults With Hemophilia B

MORN

Morningstar shares are trading higher. The company reported Q2 financial results yesterday.

Carrier Global Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CARR#NYSE">CARR</a>) shares are trading lower after it reported <a href="https://www.benzinga.com/pressreleases/24/07/n39952796/carrier-reports-strong-second-quarter-2024-results" target="_blank" rel="noreferrer noopener">second-quarter FY24 results</a>.
Net sales rose&nbsp;12%&nbsp;Y/Y to&nbsp;$6.70 billion, missing the consensus of&nbsp;$7.00 billion.
Revenue included 2% organic growth and a 12% boost from the Viessmann Climate Solutions acquisition, partially offset by a 2% decline from divestitures.
GAAP operating profit of&nbsp;$3.7 billion&nbsp;was up over&nbsp;650%&nbsp;from last year, primarily due to the gain on the sale of Access Solutions and the addition of Viessmann Climate Solutions.&nbsp;Adjusted operating profit of&nbsp;$1.2 billion&nbsp;was up&nbsp;26%&nbsp;Y/Y,&nbsp;driven by contribution from Viessmann Climate Solutions.
Carrier Chairman &amp; CEO&nbsp;David Gitlin said, &#8220;We delivered solid sales and roughly&nbsp;30%&nbsp;orders growth as we continue to outperform in our markets. Our strong operational execution drove 200 basis points of adjusted operating margin expansion and double-digit adjusted earnings growth.&#8221;
The company reported adjusted EPS of&nbsp;$0.87, beating<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener"> the consensus of&nbsp;$0.84</a>.
Operating cash flow totaled&nbsp;$660 million, and capital expenditures were&nbsp;$111 million, resulting in a free cash flow&nbsp;of&nbsp;$549&nbsp;million.
The company exited the quarter with cash and cash equivalents worth&nbsp;$2.92 billion.
Gitlin added that, &#8220;Year-to-date, we also closed on <a target="_blank" href="https://www.benzinga.com/markets/equities/24/06/39135922/honeywell-takes-flight-boosts-guidance-closes-carrier-global-transaction" rel="noreferrer noopener">two of our four business exits</a>, and the remaining two continue to track well. The proceeds from the exits, combined with our strong free cash flow performance, have enabled us to reduce net debt by about&nbsp;$5 billion&nbsp;in the quarter and we now plan to repurchase about&nbsp;$1 billion&nbsp;of shares in the second half of 2024.&#8221;
FY24&nbsp;Outlook: Carrier reiterated adjusted EPS outlook of&nbsp;$2.80-$2.90&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">versus the&nbsp;$2.86&nbsp;estimate</a>.&nbsp;
The company reduced its sales&nbsp;outlook&nbsp;to ~$25.5 billion&nbsp;from previously expected ~$26 billion&nbsp;(vs.&nbsp;$25.555 billion estimate), with&nbsp;mid-single-digit organic growth.
Carrier reiterated outlook for an adjusted operating margin of&nbsp;15.5%&nbsp;and a free cash flow of ~$0.4 billion.
Investors can gain exposure to the stock via&nbsp;First Trust US Equity Opportunities ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FPX#NYSE">FPX</a>) and&nbsp;Carbon Collective Climate Solutions U.S. Equity ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCSO#NASDAQ">CCSO</a>).
Price Action: CARR shares are down 2.73% at $64.19 at the last check Thursday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/39958034" target="_blank" rel="noreferrer noopener">Honeywell Beats On Q2 Earnings, Thanks To Aerospace Strength; Lowers FY24 EPS Outlook</a></li>
</ul>

Earnings

Equities

Guidance

Buybacks

CARR

CCSO

Carrier Global Delivers Mixed Q2 Results, Plan To Repurchase $1B Shares In H2

ODFL

Old Dominion Freight Line shares are trading higher after multiple analysts raised their price targets on the stock.

Truist Securities analyst Bill Chappell maintains Coca-Cola (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>) with a Buy and raises the price target from $65 to $70.

Truist Securities Maintains Buy on Coca-Cola, Raises Price Target to $70

Cantor Fitzgerald analyst Sarah James reiterates Universal Health Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) with a Underweight and maintains $162 price target.

Reiteration

Cantor Fitzgerald Reiterates Underweight on Universal Health Servs, Maintains $162 Price Target

ABBV

AbbVie shares are trading higher after the company reported better-than-expected Q2 financial results and raised its 2024 guidance.

Thermo Fisher shares are trading higher after multiple analysts raised their price targets on the stock following Wednesday's earnings report.

Truist Securities analyst David Macdonald reiterates Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) with a Buy and raises the price target from $155 to $170.

Truist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $170

GILD

Gilead Sciences shares are trading higher after the company announced new 5-year data reinforcing Biktarvy as a long term HIV treatment.

Macro Economic Events

Economics

Federal Reserve

U.S. Treasury's Yellen Says BidenAdministration To Continue Commitment To Multilateralism, Building Ties With Allies; Urges Faster Progress On Debt Restructuring For Poor Countries, More Support To Countries Struggling With High Debt Service Costs; Will Keep Pressing China To Change Economic Model That Channels Too Much Savings, Too Many Subsidies Into Manufacturing, Creating Excess Capacity; U.S. Concerns Over China's Excess Capacity And Its Threats To Workers And Firms Are 'Shared By Many' At G20 Meetings

Truist Securities analyst William Stein maintains TE Connectivity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEL#NYSE">TEL</a>) with a Hold and raises the price target from $151 to $156.

Truist Securities Maintains Hold on TE Connectivity, Raises Price Target to $156

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-ratings/">analyst ratings page</a>.
<ul>
<li>Citigroup analyst Paul Lejuez downgraded the rating for Lululemon Athletica Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) from Buy to Neutral, while cutting the price target from $415 to $300. Lululemon shares settled at $272.06 on Wednesday. <a href="https://www.benzinga.com/quote/LULU/analyst-ratings">See how other analysts view this stock. See how other analysts view this stock.</a></li>
<li>Argus Research analyst Kevin Heal downgraded Zions Bancorporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>) from Buy to Hold. Zions Bancorp shares closed at $50.98 on Wednesday. <a href="https://www.benzinga.com/quote/ZION/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities analyst Travis Steed downgraded the rating for Edwards Lifesciences Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>) from Buy to Neutral, while lowering the price target from $105 to $75. Edwards Lifesciences shares closed at $86.95 on Wednesday. <a href="https://www.benzinga.com/quote/EW/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Stifel analyst Matthew Smith downgraded Lamb Weston Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LW#NYSE">LW</a>) from Buy to Hold and slashed the price target from $115 to $60. Lamb Weston shares closed at $56.42 on Wednesday. <a href="https://www.benzinga.com/quote/LW/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Needham analyst Quinn Bolton downgraded the rating for MaxLinear, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MXL#NASDAQ">MXL</a>) from Buy to Hold. MaxLinear shares closed at $22.29 on Wednesday. <a href="https://www.benzinga.com/quote/MXL/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39958828/wall-streets-most-accurate-analysts-weigh-in-on-3-energy-stocks-with-over-6-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Energy Stocks With Over 6% Dividend Yields</a></li>
</ul>

Downgrades

Markets

Trading Ideas

LULU

ZION

This Lululemon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

U.S. Treasury's Yellen Says U.S. Q2 GDP, Inflation Data On Thursday Affirms That U.S. On Path To Steady Growth, Declining Inflation; Strong U.S. Growth Due To Biden-Harris Administration's Economic Plan, With 15.7M Jobs Created Since Taking Office; Prices Still Too High For Many Americans, Administration Working To Address Cost Pressures In Housing, Healthcare, Energy

U.S. Treasury's Yellen Says Biden Has Driven A 'Remarkable Economic Recovery,' Restored U.S. Standing In World; 'Deeply Proud' To Serve With Biden And Harris, Looks Forward To Continue Advancing U.S. Leadership Abroad, Strong Economic Results At Home; Global Economy Remains Resilient, Driven In Large Part By U.S. Economic Performance

New Delhi City Police Summons Diageo India CEO To Appear At Investigation Into Case Linked To Payments By Government Agencies For Liquor Purchases

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

RENEWABLES INFRA GRP LTD by Renewables Infrastructure Group, Ltd.

News

Latest news for RENEWABLES INFRA GRP LTD by Renewables Infrastructure Group, Ltd. (OTC:RWFRF) Stock